SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-206657
Filing Date
2022-07-29
Accepted
2022-07-29 16:21:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d378183ds3.htm S-3 217632
2 EX-5.1 d378183dex51.htm EX-5.1 10573
3 EX-23.1 d378183dex231.htm EX-23.1 1583
4 EX-FILING FEES d378183dexfilingfees.htm EX-FILING FEES 16538
5 GRAPHIC g378183g0729230028255.jpg GRAPHIC 2534
6 GRAPHIC g378183g32v89.jpg GRAPHIC 32628
  Complete submission text file 0001193125-22-206657.txt   292708
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266410 | Film No.: 221121088
SIC: 2836 Biological Products, (No Diagnostic Substances)